Stock REGN REGENERON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
973.8 USD +0.60% Intraday chart for Regeneron Pharmaceuticals, Inc. +3.86% +10.87%
May. 08 Regeneron Pharmaceuticals, Inc. Announces Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness Within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks CI
May. 07 UBS Raises Regeneron Pharmaceuticals Price Target to $1,124 From $1,099, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
REGENERON PHARMACEUTICALS, INC.
Bio Therapeutic Drugs
+0.60%+3.86%+10.87%+29.00%+200.40% 104B
Bullish
Bullish
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. REGN Stock
  4. Charts Regeneron Pharmaceuticals, Inc.
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW